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Oxidation-Reduction Reactions of Metal Ions
Dean E. Carter
Department of Pharmacology and Toxicology, College of Pharmacy, University ofArizona, Tucson, Arizona
Several metal or metalloid ions exist in multiple oxidation states and can undergo electron transfer reactions that are important in biological and envi-
ronmental systems. There are endogenous metal ions such as iron, copper, and cobalt that participate in oxidation-reduction reactions with species
of oxygen like molecular dioxygen, superoxide, and hydrogen peroxide. These reactions may be modulated by endogenous reducing agents such as
glutathione, ascorbate, and tocopherol. The reactions can be described in terms of thermodynamics through the use of standard electrode poten-
tials. A favorable reaction will depend on the concentrations of the reactants and may depend on the pH and/or on the presence of organic ligands
that form complexes with the metal or metalloid. Arsenate (As(V)) can react with glutathione in buffered aqueous solutions to produce arsenite
(AslIl)) and oxidized glutathione. This reaction may be important in the methylation reactions of arsenic. Arsenic species can decrease the red blood
cell levels of reduced glutathione, but the products of oxidation and the mechanism of oxidation are more complex than those found in water alone.
Chromium (VI) is thought to interact with DNA after first reacting with a reducing agent such as glutathione to form lower oxidation states of
chromium. These examples illustrate the importance of oxidation-reduction reactions for toxic metals and metalloids. - Environ Health Perspect
103(Suppl 1):17-19 (1995)
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Introduction
Chemical toxicity depends upon several
chemical properties including reactions
that have reached equilibrium (binding
constants), acid base behavior, electron
transfer reactions (oxidation-reduction)
and reaction rates. Often these chemical
terms are described as a component of
metabolism or the mechanism of toxicity
and are called "bioactivation," a process in
which "reactive intermediates" are formed
and subsequently react with critical endoge-
nous compounds to form "adducts." These
reactions are generally oxidations in which
oxygen atoms are added to carbon or nitro-
gen atoms of a molecule.
Metals and metalloids can bind directly
with endogenous compounds to form com-
plexes. These complexes may or may not
be the toxic compounds, but rather they
may be a transport form ofthe metal ion or
even a species that protects against the toxi-
city ofthe free metal ion. In addition, elec-
tron transfer reactions occur; some
metal(loid)s transfer electrons between sta-
ble oxidation states and this process may
lead to changes in the site and/or route of
This paper was presented at the Joint United States-
Mexico Conference on Fate, Transport, and
Interactions of Metals held 14-16 April 1993 in
Tucson, Arizona.
This work was partially supported by National
Institute of Environmental Health Sciences grant P42-
ES4940. The author acknowledges the contributions
of Susan Hurt in the preparation of this manuscript.
Address correspondence to Dr. Dean E. Carter,
College of Pharmacy, University of Arizona, Tucson,
AZ 85721. Telephone (602) 626-3977. Fax (602) 626-
2466. E-mailcarter~toxic.pharm.arizona.edu
toxicity. There is a significant possibility
for redox cycling between the oxidation
states of metal ions such that electrons are
transferred between endogenous com-
pounds; this may create much greater
effects than would be predicted on the
basis ofstoichiometric quantities (doses) of
the metal ion alone.
The term "metal speciation" has been
used to describe some of these chemical
forms and the oxidation state and/or the
composition of the metal complex in the
biological system. When this concept of
metal species is combined with the trans-
port and toxicity ofmetals, its impact on
the complexity ofthe system can be appre-
ciated.
Oxidation-Reduction:
Electron Transfer Reactions
Many important biological reactions occur
with the transfer of one or more electrons
either directly or with the transfer of oxy-
gen atoms. There are several substances in
the functioning organism that are involved
with these reactions. These include metal
ions at the active site of enzymes:
Fe(II)-Fe(III), Cu(I)-Cu(II), Co(II)-
Co(III); endogenous oxidizing agents:
O°- (superoxide), H202 (hydrogen perox-
ide), 02 (oxygen); and endogenous reduc-
ing agents: O2-, H202, glutathione,
ascorbate, tocopherol, NADPH.
The oxygen-related species arise from
the conversion of molecular dioxygen to
water by an organism to produce energy.
02+e - O° +e - H202 +2e - H20
The key step is the initial formation of
the superoxide radical formed as a by-prod-
uct ofthe use ofdioxygen as an oxidant in
respiration and oxidative metabolic
processes. The amount of dioxygen con-
verted to superoxide during aerobic respira-
tion varies from 1 to 4% (1). Whenever an
electron tranfer system operates in micro-
somes or mitochrondria, superoxide is pro-
duced. The radical can also be produced
directly when xanthine is oxidized by xan-
thine oxidase and during phagocytosis
when a burst ofsuperoxide is produced by
a membrane-bound NADPH oxidase in all
phagocytic cells. In the red blood cell,
superoxide can be formed from the auto-
oxidation ofoxyhemoglobin.
HbFe(II)02 -> HbFe(III)DOp->
HbFe(III) + O°-
The concentration ofthese oxidizing species
is kept under tight enzymatic control by
superoxide dismutase (SOD) for superoxide
and by catalase and glutathione peroxidase
for hydrogen peroxide. The concentration
ofsuperoxide is maintained in vivo at 10-10
to 1011 M, whereas hydrogen peroxide is
maintained at 10 7 to 10 8 M (1).
In contrast to these low concentrations
for the oxygen-based oxidizing species,
some of the endogenous reducing agents
are maintained at much higher concentra-
tions. Ascorbate and glutathione concen-
trations in cell cytosol are found at
millimolar levels and tocopherols are in
high concentrations in the lipids in the cell
(e.g., membranes).
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Metal(loid)s that can participate in oxi-
dation-reduction reactions can react with
these species either to protect against toxic-
ity or to enhance toxicity. The well-known
Fenton reaction between endogenous iron
and hydrogen peroxide generates the
extremely reactive hydroxyl radical.
Fe(II) + H202 -* Fe(III) + OH- + OHF
The hydroxyl radical can initiate lipid
peroxidation and it reacts readily with pro-
teins. The Fenton reaction, as written,
oversimplifies the process, as it is doubtful
that Fe(II) exists free in biological solu-
tions and Fe(III) is very insoluble as its
hydroxide at physiological pH. The actual
species produced may be metal(loids) at
higher oxidation states after subsequent
reactions with the hydroxyl radical or
other radicals formed, followed by reac-
tions between the metal(loid) and cellular
macromolecules (1). These reactions have
been examined for the endogenous metals
iron and copper, but it is likely that cer-
tain toxic metals also react with these
endogenous oxidizing and reducing agents
as well as the endogenous metal ions.
These toxic metal(loid)s that change oxi-
dation states are As(III)-As(V),
Au(O)-Au(I)-Au(III), Cr(III)-Cr(VI),
Hg(O)-Hg(I)-Hg(II),
Mn(II)-MnkiII)-Mn(IV), V(III)-V(V),
[Ni(II)-Ni(III)]. Other toxic metals are
unlikely to change oxidation states as a
part of their toxic action. These are
A1(IDI, Cd(II), MbII).
Oxidation-Reduction
Reactions and Standard
Reduction Potential
Chemical reactions can be described in
terms of thermodynamics and the free-
energy change between products and reac-
tants. An oxidation-reduction reaction
which has reached equilibrium has a
change in free-energy of zero. The free-
energy change of a chemical reaction can
be described as a function ofthe cell poten-
tial ofa hypothetical cell in which electron
transfer occurs.
AG° = -nFE0
AG =-nFEcell
These cell potentials and the standard elec-
trode potentials of the half cell reactions
may be used to predict ifspecific reactions
will occur spontaneously. A chemical reac-
tion can be separated into its component
half reactions that can be combined to
determine ifthe reaction is thermodynami-
cally favorable.
The example used is the reduction of
Fe(III) by superoxide radical anion. This is
an important reaction in the generation of
the hydroxyl radical. Ifthe potential for the
reaction is a positive number, the reaction
will be energetically favored.
Fe(III) + e- -* Fe(II)
°2- * 02 + e
E°= +0.77V
E° = +0.33 V
Fe(III) +O°- + Fe(II) +O2 Ecell = 1-1 V
The reduction potential of the couple,
OpJ/02, at 25°C at 1 atm of oxygen is
-0.33 V at 1 atm ofoxygen, but the sign is
reversed when written as an oxidation.
Other important reducing agents are: glu-
tathione -0.23 V, NADPH -0.32V, and
vitamin C-0.058 V (1).
Effect of pH on
Reduction Potential
If the reaction requires hydrogen or
hydroxyl ions to balance the equation, then
the pH of the solution will affect the cell
potential. Thus, it is possible that a reac-
tion could change from being favorable to
being unfavorable based on the pH of the
solution.
Effect ofComplex Formation
on Reduction Potential
Metal ions are electropositive in nature
and have a very high affinity for electron-
rich molecules-so much so that they
avidly bind the oxygen atom in water mol-
ecules in aqueous solutions. Biological sys-
tems have a large variety of functional
groups on molecules that are rich in elec-
trons; carboxylic acids, heterocyclic nitro-
gens, amines and thiol groups on amino
acids, vitamins, proteins, lipids, RNA and
DNA provide strong binding sites for
metal(loid)s. Binding to these electron-
rich molecules changes the electron den-
sity around the metal(loid) and, thus,
changes the reduction potential of the
metal(loid).
For example, the standard reduction
potential for the reaction, Co(III) -e
Co(II) is different when determined in
water compared to the value obtained
when complexed with ethylenediamine.
Co(III) + e -> Co(II) E° = +1.95 V
Co(en)33+ + e- - Co(en)32+ E =-0.2 V
Examples of Oxidation
Reduction Reactions
with Metal(loid)s
ArsenicVSpecieswth Glutathione
Inorganic arsenicals such as As(V) and
As(III) are very toxic, but organisms have
the ability to detoxify the arsenic through
the formation of methylated metabolites:
monomethylarsonic acid (As(V)) and
dimethylarsinic acid (As(V)) in mammals
and further to trimethylarsinic oxide (As(V))
and trimethylarsine (As(III)) in certain bac-
teria and fungi (2). This metabolism
appears to involve the formation ofAs(III)
and As(V) species at various steps in the
process. Ifthe various steps in this process
could be understood, the detoxification of
arsenic maybe able to be manipulated.
Reactions ofarsenate and arsernite with
glutathione were studied in aqueous buffer
solutions to characterize the chemistry of
that reaction (3). The reactions in solution
were studied using high resolution nuclear
magnetic resonance; the products of the
reactions were isolated and characterized
by mass spectrometry.
The results showed an electron transfer
reaction between As(V) and glutathione to
form As(III) and oxidized glutathione
(GSSG).
AsOj3+2 GSH ->AsO33 +GSSH+H20
As additional GSH was added after the
reduction to As(III) was complete, a com-
plex between the As(III) and GSH formed.
AsO3 + 3 GSH -> As(SG)3 + 3 OH 3
This complex has a unique NMR spec-
trum, can be isolated as a solid, and gives a
mass spectrum consistent with this struc-
ture. Analogous electron transfer reactions
occurred between glutathione and the two
methylated species ofAs(V) and the GSH
complexes were formed.
CH3AsO(OH)2 + 4 GSH ->
CH3As(SG)2 + GSSG + 2 H20
(CH3)2AsO(OH) + 3 GSH ->
(CH3)2As(SG) + GSSG + H20
There is in vivo evidence for the reduction
of arsenate to arsenite; both species are
found in blood and urine after administra-
tion ofAs(V). However, there is no in vivo
evidence for the corresponding methylated
As(III) species. Their function is unclear, as
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they have never been identified in an
organism, but their existence has been pos-
tulated in the methylation reaction; the
methylation reaction has been thought to
be an oxidative methylation that involves a
change in oxidation state from As(III) to
As(V) (4).
+CH3 +2e
As(III)O3-> CH3As(V)O(OH)2->
+CH3
CH3As(III)(OH)2 > (CH3)2AsO(OH)
Thus, the role of glutathione could be to
provide the electrons for the reduction of
As(V) to As(III) and the GSH complex
could be the substrate for the methylating
enzymes.
The reduction of arsenic species by
GSH has been studied in the red blood
cell, where there is little likelihood ofany
methylating enzymes being present. When
As(V) was incubated with red blood cells,
there was a slow uptake ofarsenic into the
cells, followed by a reduction in GSH lev-
els and the appearance ofAs(III). Instead
ofGSSG being formed, mixed disulfides of
GSH and protein-SH appeared (GSSPro).
This still shows that an oxidation of thiol
groups accompanied the disappearance of
GSH. However, the results appear more
complicated than the solution chemistry
reactions described above; when As(III)
was incubated with the cells, GSH levels
also declined. The reasons for this finding
are unclear and are being investigated.
CarcinogenicityofChromate
Chromate (Cr(VI)), has been found to be
carcinogenic to humans based on the
results ofseveral epidemiologic studies (5).
The target organ after inhalation of
aerosols is the respiratory tract. The exact
mechanism by which Cr(VI) compounds
cause cancer is not known, but the oxida-
tion state is critical because the other most
common oxidation state, Cr(III), is not
carcinogenic. It is known that Cr(VI) is
taken up by cells through an anion channel
that is probably also used to transport sul-
fate and phosphate. Cr(VI) has insufficient
interactions with DNA in vitro to be con-
sidered the carcinogen; significant
chromium-DNA binding was observed in
vitro only when Cr(VI) was incubated with
DNA in the presence of agents capable of
reducing Cr(VI) (5). These findings have
led to the hypothesis that Cr(VI) is taken
up by the cell in preference to other forms
of Cr and once inside the cell, reacts with
reducing agents to form the carcinogenic
species. Electron spin resonance spectro-
copy evidence indicates that there are sev-
eral possible carcinogenic species including
Cr(V), Cr(IV), thiyl (GS) and hydroxyl
(HO-) radical intermediates (5). The reac-
tions shown below are written as one-elec-
tron transfers until the stable Cr(III)
oxidation state is reached, although there is
no evidence to suggest this mechanism.
Cr(VI) + GSH 3 Cr(V) + GS-
Cr(V) + GSH - Cr(IV) + GS
Cr(IV) + GSH - Cr(III) + GS-
A number of nonenzymatic and enzy-
matic materials have shown the ability to
reduce Cr(VI). The nonenzymatic reduc-
tants include glutathione, ascorbate (vita-
min C), vitamin B2, and tocopherol
(vitamin E). The enzymatic reductants
include the mixed-function oxidase enzymes
(cytochrome P450 and cytochrome b5),
mitochondrial enzymes (complexes I, II,
and IV of the electron transport chain),
and possibly DT-diaphorase (5). Ofthese,
most of the work has focused on glu-
tathione; it is the most likely candidate
along with ascorbate, to reduce Cr(VI)
because of its high concentrations in the
cell cytosol.
Formation ofArsinefromArsenite
intheEnvironment
Arsine is the most toxic form of arsenic,
with a recommended maximal exposure to
arsine ofonly 0.05 ppm. The toxicology of
arsine is not clearly understood, but one
major effect is the hemolysis of red blood
cells followed by other effects including
kidney failure and death.
Arsine is made in the laboratory by
hydrolysis of arsenides with acid (e.g.,
Zn3As2) or by reduction ofarsenic trioxide
with reducing agents such as sodium boro-
hydride or zinc in acid. It is commonly
stated that arsine is accidentally generated
when arsenic salts react with nascent
hydrogen (abnormally reactive hydrogen),
but this seems unlikely because the reduc-
tion of arsenous acid by hydrogen is not
thermodynamically favored.
3H2 + HAsO2 - AsH3 + 2H20
E = -0.36 V
The typical conditions that resulted in acci-
dental arsine formation include water solu-
tions ofarsenic, acid or base, and a metal in
its elemental form. Some examples include
a) arsenic and an aluminum ladder in
water, b) acid sludge in a galvanized
bucket, c) flue dust mixed with sulfuric
acid and metallic zinc, d) an aluminum
tank containing sodium hydroxide solu-
tion, or e) metallic aluminum dross and
hot water. It is more likely that the arsenic
reacts with the metal after the metal oxide
coating on the surface is removed by the
acid or base. The role ofthe water is to dis-
solve the metal ion after it is formed.
2A1(O) + HAsO2 + 6H+ -
2A1(III) + AsH3 + 2H20
E=+2.96V
Reactions of this type with aluminum,
zinc, iron, cadmium, nickel, tin, and lead
in the metallic form are thermodynamically
favored. Therefore, arsine may be gener-
ated in unexpected places if the solution
conditions are appropriate.
Conclusions
Several metal species react in biological and
environmental systems to participate in
electron transfer reactions in which they
change oxidation states. As different species
are formed, there are significant changes in
toxicity. Our understanding of these
processes is incomplete and the determina-
tion ofthe actual metal species responsible
for toxicity promises to be the next frontier
in metal toxicity.
REFERENCES
1. Goldstein S, Czapski G. Transition
metal ions and oxygen radicals
In:International Review of Experi-
mental Pathology, Vol 31 (Richter
GW, Solez K, Aisen P, Cohen G, eds).
New York:Academic Press, 1990;
133-164.
2. Vahter M. Metabolism ofarsenic. In:
Biological and Environmental Effects
ofArsenic (Fowler B, ed). New York:
Elsevier, 1983;171-198.
3. Scott N, Hatlelid KM, MacKenzie
NE, Carter DE. Reactions of arsenic
(III) and arsenic (V) species with glu-
tathione. Chem Res Toxicol 6:
102-106 (1993).
4. Buchet JP, Lauwerys R. Role of thiols
in the in vitromethylation ofinorganic
arsenic by rat liver cytosol. Biochem
Pharmacol 37:3149-3153 (1988).
5. Alcedo JA, Wetterhahn KE.
Chromium toxcity and carcinogenesis.
In: International Review of Experi-
mental Pathology, Vol 31 (Richter GW,
Solez K, Aisen P, Cohen G, eds). New
York:Academic Press, 1990;85-108.
Volume 103, Supplement 1, February 1995 19